| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |